Migraine drug may stop altitude sickness before it starts

This study tests whether a single injection of fremanezumab, a drug used to prevent migraines, can stop acute mountain sickness (AMS) in healthy adults. Thirty volunteers will receive either the drug or a placebo one week before climbing to a high-altitude hut. Researchers will track symptoms like headache and nausea to see if the drug reduces AMS severity.